Vascular Biology |
From the Department of Pathology, University of Washington, Seattle.
Correspondence to Michael A. Reidy, PhD, Department of Pathology, University of Washington, Box 357335, Seattle WA 98195. E-mail mar1{at}u.washington.edu
AbstractThe phosphoinositide 3-kinase [PI(3)K] pathway is a key signaling pathway important for replication of mammalian cells. In this study, we examined the role of PI(3)K in smooth muscle cell (SMC) replication after balloon catheter injury of rat carotid arteries. Protein kinase B (PKB), a downstream target of PI(3)K, was phosphorylated at 30 and 60 minutes after injury and to a lesser degree after 6 hours and 1 and 2 days but not after 7 days. Wortmannin (10 µg per rat), a PI(3)K inhibitor, given to rats 60 and 5 minutes before and 11 hours after balloon injury, reduced the levels of phosphorylated PKB. SMC replication quantified between 24 to 48 hours was significantly reduced compared with control replication, as were the levels of cyclin D1. Wortmannin was also administered to rats between days 7 and 8 and between days 7 and 9 after balloon catheter injury. A reduction in levels of phosphorylated PKB was detected, but no decrease in the replication of intimal SMCs was observed in either experiment. These data demonstrate that the PI(3)K signal transduction pathway plays an important role in medial but not intimal SMC replication.
Key Words: balloon injury smooth muscle cell replication protein kinase B wortmannin
This article has been cited by other articles:
![]() |
W.-F. Chiou, C.-C. Chen, and B.-L. Wei 3,4-Di-O-Caffeoylquinic Acid Inhibits Angiotensin-II-induced Vascular Smooth Muscle Cell Proliferation and Migration by Downregulating the JNK and PI3K/Akt Signaling Pathways Evid. Based Complement. Altern. Med., September 14, 2009; (2009) nep140v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Nemenoff, P. A. Simpson, S. B. Furgeson, N. Kaplan-Albuquerque, J. Crossno, P. J. Garl, J. Cooper, and M. C.M. Weiser-Evans Targeted Deletion of PTEN in Smooth Muscle Cells Results in Vascular Remodeling and Recruitment of Progenitor Cells Through Induction of Stromal Cell-Derived Factor-1{alpha} Circ. Res., May 9, 2008; 102(9): 1036 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Albinsson and P. Hellstrand Integration of signal pathways for stretch-dependent growth and differentiation in vascular smooth muscle Am J Physiol Cell Physiol, August 1, 2007; 293(2): C772 - C782. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Wu, M. Bond, G. B. Sala-Newby, and A. C. Newby Altered S-Phase Kinase-Associated Protein-2 Levels Are a Major Mediator of Cyclic Nucleotide-Induced Inhibition of Vascular Smooth Muscle Cell Proliferation Circ. Res., May 12, 2006; 98(9): 1141 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kozai, M. Eto, Z. Yang, H. Shimokawa, and T. F. Luscher Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway Cardiovasc Res, December 1, 2005; 68(3): 475 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Li, C. Zhang, S. Schaefer, A. Estes, and K. U. Malik ANG II-induced neointimal growth is mediated via cPLA2- and PLD2-activated Akt in balloon-injured rat carotid artery Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2592 - H2601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jonas, E. R. Edelman, A. Groothuis, A. B. Baker, P. Seifert, and C. Rogers Vascular Neointimal Formation and Signaling Pathway Activation in Response to Stent Injury in Insulin-Resistant and Diabetic Animals Circ. Res., September 30, 2005; 97(7): 725 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shen, S. P. Halenda, M. Sturek, and P. A. Wilden Cell-Signaling Evidence for Adenosine Stimulation of Coronary Smooth Muscle Proliferation via the A1 Adenosine Receptor Circ. Res., September 16, 2005; 97(6): 574 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Mehrhof, R. Schmidt-Ullrich, R. Dietz, and C. Scheidereit Regulation of Vascular Smooth Muscle Cell Proliferation: Role of NF-{kappa}B Revisited Circ. Res., May 13, 2005; 96(9): 958 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Gerasimovskaya, D. A. Tucker, and K. R. Stenmark Activation of phosphatidylinositol 3-kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast proliferation J Appl Physiol, February 1, 2005; 98(2): 722 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, X.-L. Niu, A. M. Pippen, B. H. Annex, and C. D. Kontos Adenovirus-Mediated Intraarterial Delivery of PTEN Inhibits Neointimal Hyperplasia Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 354 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zahradka, G. Harding, B. Litchie, S. Thomas, J. P. Werner, D. P. Wilson, and N. Yurkova Activation of MMP-2 in response to vascular injury is mediated by phosphatidylinositol 3-kinase-dependent expression of MT1-MMP Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2861 - H2870. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mifune, H. Ohtsu, H. Suzuki, G. D. Frank, T. Inagami, H. Utsunomiya, P. J. Dempsey, and S. Eguchi Signal transduction of betacellulin in growth and migration of vascular smooth muscle cells Am J Physiol Cell Physiol, September 1, 2004; 287(3): C807 - C813. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Yang, H.-S. Kim, K.-W. Park, H.-J. You, S.-I. Jeon, S.-W. Youn, S.-H. Kim, B.-H. Oh, M.-M. Lee, Y.-B. Park, et al. Celecoxib, a Cyclooxygenase-2 Inhibitor, Reduces Neointimal Hyperplasia Through Inhibition of Akt Signaling Circulation, July 20, 2004; 110(3): 301 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-F. Yan, R. Ramasamy, L. G Bucciarelli, T. Wendt, L. K Lee, B. I Hudson, D. M Stenr, E. Lalla, S. Du Yan, L. L. Rong, et al. RAGE and its ligands: a lasting memory in diabetic complications? Diabetes and Vascular Disease Research, May 1, 2004; 1(1): 10 - 20. [Abstract] [PDF] |
||||
![]() |
M. E. Mabrouk, Q. N. Diep, K. Benkirane, R. M. Touyz, and E. L. Schiffrin SAM68: a downstream target of angiotensin II signaling in vascular smooth muscle cells in genetic hypertension Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1954 - H1962. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zohlnhofer, T. G. Nuhrenberg, F.-J. Neumann, T. Richter, A. E. May, R. Schmidt, K. Denker, M. A. Clauss, A. Schomig, and P. A. Baeuerle Rapamycin Effects Transcriptional Programs in Smooth Muscle Cells Controlling Proliferative and Inflammatory Properties Mol. Pharmacol., April 1, 2004; 65(4): 880 - 889. [Abstract] [Full Text] |
||||
![]() |
P. M. Mourani, P. J. Garl, J. M. Wenzlau, T. C. Carpenter, K. R. Stenmark, and M. C.M. Weiser-Evans Unique, Highly Proliferative Growth Phenotype Expressed by Embryonic and Neointimal Smooth Muscle Cells Is Driven by Constitutive Akt, mTOR, and p70S6K Signaling and Is Actively Repressed by PTEN Circulation, March 16, 2004; 109(10): 1299 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Garl, J. M. Wenzlau, H. A. Walker, J. M. Whitelock, M. Costell, and M. C.M. Weiser-Evans Perlecan-Induced Suppression of Smooth Muscle Cell Proliferation Is Mediated Through Increased Activity of the Tumor Suppressor PTEN Circ. Res., February 6, 2004; 94(2): 175 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Su, E. M. Smolock, K. N. Marcel, and R. S. Moreland Phosphatidylinositol 3-kinase modulates vascular smooth muscle contraction by calcium and myosin light chain phosphorylation-independent and -dependent pathways Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H657 - H666. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Williams, C. Li, T. Ha, T. Ozment-Skelton, J. H. Kalbfleisch, J. Preiszner, L. Brooks, K. Breuel, and J. B. Schweitzer Modulation of the Phosphoinositide 3-Kinase Pathway Alters Innate Resistance to Polymicrobial Sepsis J. Immunol., January 1, 2004; 172(1): 449 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Yan, R. Ramasamy, Y. Naka, and A. M. Schmidt Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond Circ. Res., December 12, 2003; 93(12): 1159 - 1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-H. Zhou, T.-S. Lee, T.-C. Tsou, F. Rannou, Y.-S. Li, S. Chien, and J. Y.-J. Shyy Stent Implantation Activates Akt in the Vessel Wall: Role of Mechanical Stretch in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, November 1, 2003; 23(11): 2015 - 2020. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. L. Wang, I. Gurevich, and B. Draznin Insulin Affects Vascular Smooth Muscle Cell Phenotype and Migration Via Distinct Signaling Pathways Diabetes, October 1, 2003; 52(10): 2562 - 2569. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Shin, H. J. Lee, M. Nishida, M.-S. Lee, R. Tamura, S. Yamashita, Y. Matsuzawa, I.-K. Lee, and G. Y. Koh Betacellulin and Amphiregulin Induce Upregulation of Cyclin D1 and DNA Synthesis Activity Through Differential Signaling Pathways in Vascular Smooth Muscle Cells Circ. Res., August 22, 2003; 93(4): 302 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dugourd, M. Gervais, P. Corvol, and C. Monnot Akt Is a Major Downstream Target of PI3-Kinase Involved in Angiotensin II-Induced Proliferation Hypertension, April 1, 2003; 41(4): 882 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Goncharova, A. J. Ammit, C. Irani, R. G. Carroll, A. J. Eszterhas, R. A. Panettieri, and V. P. Krymskaya PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L354 - L363. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang and C. D. Kontos Inhibition of Vascular Smooth Muscle Cell Proliferation, Migration, and Survival by the Tumor Suppressor Protein PTEN Arterioscler Thromb Vasc Biol, May 1, 2002; 22(5): 745 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kimura, K. Sasaki, T. Meguro, and J. H. Zhang Phosphatidylinositol 3-Kinase Inhibitor Failed to Reduce Cerebral Vasospasm in Dog Model of Experimental Subarachnoid Hemorrhage Stroke, February 1, 2002; 33(2): 593 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Reynolds, S. Eguchi, G. D. Frank, and E. D. Motley Signaling Mechanisms of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Vascular Smooth Muscle Cells Hypertension, February 1, 2002; 39(2): 525 - 529. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |